These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 5892385)
81. [Adverse side effects caused by topically applied antiviral agents in herpetic keratitis]. Chen CW Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Aug; 5(8):416-29. PubMed ID: 2480457 [TBL] [Abstract][Full Text] [Related]
82. [IDU IN THE TREATMENT OF HERPETIC KERATITIS]. GWOZDZ E Klin Oczna; 1964; 34():211-8. PubMed ID: 14210059 [No Abstract] [Full Text] [Related]
83. [ON THE TREATMENT OF HERPETIC KERATITIS WITH IDU (5-IODO-2'-DESOXYURIDINE)]. MACH H; WILCZEK Z Klin Monbl Augenheilkd; 1965 Mar; 146():270-4. PubMed ID: 14286376 [No Abstract] [Full Text] [Related]
84. CONTROLLED STUDIES OF IDU IN THE TREATMENT OF HERPETIC KERATITIS. PATTERSON A; FOX AD; DAVIES G; MAGUIRE C; HOLMESSELLERS PJ; WRIGHT P; RICE NS; COBB B; JONES BR Trans Ophthalmol Soc U K (1962); 1963; 83():583-91. PubMed ID: 14123174 [No Abstract] [Full Text] [Related]
85. [Clinico-statistical study of cases of herpetic keratitis hospitalized at the Jassy Ophthalmological Clinic in the period 1970-1974]. Vancea PP; Călin A; Colev G; Popescu V Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1977; 21(2):111-4. PubMed ID: 897264 [No Abstract] [Full Text] [Related]
86. [CLINICAL OBSERVATIONS ON THE TREATMENT OF HERPETIC KERATITIS WITH 5-IODO-2'-DEOXYURIDINE (IDU)]. JOVICEVIC B; NABLI B Tunis Med; 1963; 41():321-5. PubMed ID: 14118451 [No Abstract] [Full Text] [Related]
87. A double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis. Pavan-Langston D; Dohlman CH Am J Ophthalmol; 1972 Jul; 74(1):81-8. PubMed ID: 4338612 [No Abstract] [Full Text] [Related]
88. HSV1 strain sensitivity in experimental rabbit keratitis: evolution under repeated topical IDU administrations. Denis J; Langlois M; Elkaim M; Amiel C; Aymard M; Huraux JM Curr Eye Res; 1987 Jan; 6(1):39-45. PubMed ID: 3030653 [TBL] [Abstract][Full Text] [Related]
89. Idoxuridine and iodization in the treatment of simple dendritic ulceration. Austin DJ; Walker WM Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):553. PubMed ID: 4534190 [No Abstract] [Full Text] [Related]
90. The treatment of herpetic stromal disease. Aquavella JV Eye Ear Nose Throat Mon; 1972 Oct; 51(10):374-81. PubMed ID: 4342571 [No Abstract] [Full Text] [Related]
95. CYTOSINE ARABINOSIDE (CA) AND OTHER NUCLEOSIDES IN HERPES VIRUS INFECTIONS. UNDERWOOD GE; WISNER CA; WEED SD Arch Ophthalmol; 1964 Oct; 72():505-12. PubMed ID: 14191102 [No Abstract] [Full Text] [Related]
96. Personal opinions on IDU and management of herpetic keratitis in its three different stages: epithelial, non-ulcerative stromal (metaherpetic) and chronic, ulcerative stromal. ALLEN J; DeVOE AG; HOGAN M; MAUMENEE AE; McLEAN JM; TROUTMAN R Highl Ophthalmol; 1962; 5():150-62. PubMed ID: 24546912 [No Abstract] [Full Text] [Related]
97. The effectiveness of 5-iodo-2'-deoxyuridine (IDU) on herpes simplex labialis. Gardner FM; Tennant FS Oral Surg Oral Med Oral Pathol; 1969 Sep; 28(3):451-4. PubMed ID: 5257191 [No Abstract] [Full Text] [Related]
98. [On the treatment of dendritic keratitis with p-fluorophenylalanine. (Preliminary report)]. Graupner K; Müller F Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1966 Dec; 171(2):103-4. PubMed ID: 5300792 [No Abstract] [Full Text] [Related]